The Effect of ACACB cis-Variants on Gene Expression and Metabolic Traits

Background Acetyl Coenzyme A carboxylase β (ACACB) is the rate-limiting enzyme in fatty acid oxidation, and continuous fatty acid oxidation in Acacb knock-out mice increases insulin sensitivity. Systematic human studies have not been performed to evaluate whether ACACB variants regulate gene expression and insulin sensitivity in skeletal muscle and adipose tissues. We sought to determine whether ACACB transcribed variants were associated with ACACB gene expression and insulin sensitivity in non-diabetic African American (AA) and European American (EA) adults. Methods ACACB transcribed single nucleotide polymorphisms (SNPs) were genotyped in 105 EAs and 46 AAs whose body mass index (BMI), lipid profiles and ACACB gene expression in subcutaneous adipose and skeletal muscle had been measured. Allelic expression imbalance (AEI) was assessed in lymphoblast cell lines from heterozygous subjects in an additional EA sample (n = 95). Selected SNPs were further examined for association with insulin sensitivity in a cohort of 417 EAs and 153 AAs. Results ACACB transcribed SNP rs2075260 (A/G) was associated with adipose ACACB messenger RNA expression in EAs and AAs (p = 3.8×10−5, dominant model in meta-analysis, Stouffer method), with the (A) allele representing lower gene expression in adipose and higher insulin sensitivity in EAs (p = 0.04). In EAs, adipose ACACB expression was negatively associated with age and sex-adjusted BMI (r = −0.35, p = 0.0002). Conclusions Common variants within the ACACB locus appear to regulate adipose gene expression in humans. Body fat (represented by BMI) may further regulate adipose ACACB gene expression in the EA population.

[1]  A. Mondal,et al.  Type 2 diabetes (T2D) associated polymorphisms regulate expression of adjacent transcripts in transformed lymphocytes, adipose, and muscle from Caucasian and African-American subjects. , 2011, The Journal of clinical endocrinology and metabolism.

[2]  V. Basevi Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[3]  L. Cupples,et al.  ACC2 gene polymorphisms, metabolic syndrome, and gene-nutrient interactions with dietary fat , 2010, Journal of Lipid Research.

[4]  C. Langefeld,et al.  The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetes. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  Ashis K Mondal,et al.  Distinct gene expression profiles characterize cellular responses to palmitate and oleate[S] , 2010, Journal of Lipid Research.

[6]  L. Scott,et al.  Allelic expression imbalance at high-density lipoprotein cholesterol locus MMAB-MVK. , 2010, Human molecular genetics.

[7]  B. Lowell,et al.  Gene knockout of Acc2 has little effect on body weight, fat mass, or food intake , 2010, Proceedings of the National Academy of Sciences.

[8]  T. Hansen,et al.  A Single Nucleotide Polymorphism within the Acetyl-Coenzyme A Carboxylase Beta Gene Is Associated with Proteinuria in Patients with Type 2 Diabetes , 2010, PLoS genetics.

[9]  Paul Kellam,et al.  KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. , 2010, Genes & development.

[10]  D. James,et al.  Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity. , 2010, Cell metabolism.

[11]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[12]  Hyun-soo Cho,et al.  Molecular mechanism for the regulation of human ACC2 through phosphorylation by AMPK. , 2010, Biochemical and biophysical research communications.

[13]  Kerstin Dietrich,et al.  Genetic Variation in Gpr133 Is Associated with Height: Genome Wide Association Study in the Self-contained Population of Sorbs Coordination Centre for Clinical Trials , 2022 .

[14]  A. Gerding,et al.  Soraphen, an inhibitor of the acetyl‐CoA carboxylase system, improves peripheral insulin sensitivity in mice fed a high‐fat diet , 2009, Diabetes, obesity & metabolism.

[15]  P. Deloukas,et al.  Common Regulatory Variation Impacts Gene Expression in a Cell Type–Dependent Manner , 2009, Science.

[16]  S. Wakil,et al.  Fatty acid metabolism: target for metabolic syndrome This work is supported by grants from the National Institute of Health (GM-63115), the Hefni Technical Training Foundation, and the Medallion Foundation. Published, JLR Papers in Press, December 1, 2008. , 2009, Journal of Lipid Research.

[17]  J. Castle,et al.  ACC2 Is Expressed at High Levels Human White Adipose and Has an Isoform with a Novel N-Terminus , 2009, PloS one.

[18]  Helen Roche,et al.  Prediction of the metabolic syndrome status based on dietary and genetic parameters, using Random Forest , 2008, Genes & Nutrition.

[19]  Ha Won Kim,et al.  Anti-obesity effects of Juniperus chinensis extract are associated with increased AMP-activated protein kinase expression and phosphorylation in the visceral adipose tissue of rats. , 2008, Biological & pharmaceutical bulletin.

[20]  R. Robertson,et al.  Glucolipotoxicity : Fuel Excess and-Cell Dysfunction , 2008 .

[21]  R. Robertson,et al.  Glucolipotoxicity: fuel excess and beta-cell dysfunction. , 2008, Endocrine reviews.

[22]  S. Das,et al.  Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent , 2007, Diabetologia.

[23]  R. Eckert,et al.  Curcumin Suppresses AP1 Transcription Factor-dependent Differentiation and Activates Apoptosis in Human Epidermal Keratinocytes* , 2007, Journal of Biological Chemistry.

[24]  P. Huypens Adipokines regulate systemic insulin sensitivity in accordance to existing energy reserves. , 2007, Medical hypotheses.

[25]  S. Elbein,et al.  Detection of allelic imbalance in gene expression using pyrosequencing. , 2007, Methods in molecular biology.

[26]  G. Shulman,et al.  Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. , 2006, The Journal of clinical investigation.

[27]  R. Gillies,et al.  Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction. , 2005, Analytical biochemistry.

[28]  S. Chirala,et al.  Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Wakil,et al.  Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Peter J Moate,et al.  MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. , 2003, Diabetes technology & therapeutics.

[31]  F. Field,et al.  Polyunsaturated fatty acids decrease the expression of sterol regulatory element-binding protein-1 in CaCo-2 cells: effect on fatty acid synthesis and triacylglycerol transport. , 2002, The Biochemical journal.

[32]  A. Häkkinen,et al.  Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. , 2002, The Journal of clinical endocrinology and metabolism.

[33]  R. Unger,et al.  Lipotoxic diseases. , 2002, Annual review of medicine.

[34]  Martin M. Matzuk,et al.  Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.

[35]  E. Ravussin,et al.  Energy expenditure, fat oxidation, and body weight regulation: a study of metabolic adaptation to long-term weight change. , 2000, The Journal of clinical endocrinology and metabolism.

[36]  Rena R Wing,et al.  Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. , 1999, American journal of physiology. Endocrinology and metabolism.

[37]  G. Boden Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM , 1997, Diabetes.

[38]  K. Kim,et al.  Regulation of mammalian acetyl-coenzyme A carboxylase. , 1997, Annual review of nutrition.

[39]  H. Kipen,et al.  Questions and Answers 1 , 1994 .

[40]  R N Bergman,et al.  MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. , 1986, Computer methods and programs in biomedicine.